LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: SARS-CoV-2 Vaccine-Elicited Immunity after B Cell Depletion in Multiple Sclerosis.

Baxter, Ryan M / Cabrera-Martinez, Berenice / Ghosh, Tusharkanti / Rester, Cody / Moreno, Miguel Guerrero / Borko, Tyler L / Selva, Sean / Fleischer, Chelsie L / Haakonsen, Nicola / Mayher, Ariana / Bowhay, Emily / Evans, Courtney / Miller, Todd M / Huey, Leah / McWilliams, Jennifer / van Bokhoven, Adrie / Deane, Kevin D / Knight, Vijaya / Jordan, Kimberly R /
Ghosh, Debashis / Klarquist, Jared / Kedl, Ross M / Piquet, Amanda L / Hsieh, Elena W Y

ImmunoHorizons

2024  Volume 8, Issue 3, Page(s) 254–268

Abstract: The impact of B cell deficiency on the humoral and cellular responses to SARS-CoV2 mRNA vaccination remains a challenging and significant clinical management question. We evaluated vaccine-elicited serological and cellular responses in 1) healthy ... ...

Abstract The impact of B cell deficiency on the humoral and cellular responses to SARS-CoV2 mRNA vaccination remains a challenging and significant clinical management question. We evaluated vaccine-elicited serological and cellular responses in 1) healthy individuals who were pre-exposed to SARS-CoV-2 (n = 21), 2) healthy individuals who received a homologous booster (mRNA, n = 19; or Novavax, n = 19), and 3) persons with multiple sclerosis on B cell depletion therapy (MS-αCD20) receiving mRNA homologous boosting (n = 36). Pre-exposure increased humoral and CD4 T cellular responses in immunocompetent individuals. Novavax homologous boosting induced a significantly more robust serological response than mRNA boosting. MS-α CD20 had an intact IgA mucosal response and an enhanced CD8 T cell response to mRNA boosting compared with immunocompetent individuals. This enhanced cellular response was characterized by the expansion of only effector, not memory, T cells. The enhancement of CD8 T cells in the setting of B cell depletion suggests a regulatory mechanism between B and CD8 T cell vaccine responses.
MeSH term(s) Humans ; COVID-19 Vaccines ; Multiple Sclerosis ; RNA, Viral ; COVID-19/prevention & control ; SARS-CoV-2 ; RNA, Messenger
Chemical Substances COVID-19 Vaccines ; RNA, Viral ; RNA, Messenger
Language English
Publishing date 2024-04-05
Publishing country United States
Document type Journal Article
ISSN 2573-7732
ISSN (online) 2573-7732
DOI 10.4049/immunohorizons.2300108
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top